id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/552274
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/552274 2023-05-15T16:51:28+02:00 Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit. Jóhannesson, Gauti Moya-Ortega, Maria D Asgrímsdóttir, Gudrun Marta Agnarsson, Bjarni A Lund, Sigrún H Loftsson, Thorsteinn Stefánsson, Einar Univ Iceland, Natl Univ Hosp, Dept Ophthalmol, IS-101 Reykjavik, Iceland, Univ Iceland, Natl Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland, Umea Univ, Dept Clin Sci, Umea, Sweden, Univ Iceland, Fac Pharmaceut Sci, IS-101 Reykjavik, Iceland, Oculis Ehf, Reykjavik, Iceland, Univ Iceland, Fac Med, Dept Publ Hlth, IS-101 Reykjavik, Iceland 2015 http://hdl.handle.net/2336/552274 https://doi.org/10.1089/jop.2013.0164 en eng Mary Ann Liebert, Inc. http://dx.doi.org/ 10.1089/jop.2013.0164 J Ocul Pharmacol Ther. 2014, 30 (6):464-7 1557-7732 24734973 doi:10.1089/jop.2013.0164 http://hdl.handle.net/2336/552274 Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics Archived with thanks to Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics Closed - Lokað Augnsjúkdómar Lyfjagjöf Animals Carbonic Anhydrase Inhibitors Delayed-Action Preparations Drug Delivery Systems Harderian Gland Inflammation Nanoparticles Ophthalmic Solutions Rabbits Sulfonamides Thiophenes gamma-Cyclodextrins Article 2015 ftlandspitaliuni https://doi.org/10.1089/jop.2013.0164 2022-05-29T08:22:03Z To access publisher's full text version of this article click on the hyperlink at the bottom of the page Dorzolamide nanoparticle γ-cyclodextrin eye drops may prolong the effect of dorzolamide on intraocular pressure. We test whether the nanoparticle drops have an irritating or toxic effect on the eye in an in vivo rabbit model. Eighteen pigmented rabbits were divided into 4 groups receiving dorzolamide nanoparticle γ-cyclodextrin eye drops×1/day or×2/day, Trusopt® (dorzolamide HCl)×3/day, and untreated controls that received no drops. The rabbits received treatment for 1 month. After sacrifice, 33 eyes and 25 Harderian glands were evaluated for histopathology in a masked way. Mild inflammation was seen in 19/31 eyes and 13/23 Harderian glands. The difference in inflammation (n=eyes/n=glands)between the γ-cyclodextrin nanoparticle eye drops×1/day (n=5/5),×2/day (n=5/3), Trusopt (n=7/4), or untreated control (n=2/0) groups was nonsignificant in both eyes and glands (P=0.87 and P=0.92) Acute inflammation was seen in 1 Harderian gland that received γ-cyclodextrin nanoparticle eye drops×2/day. The difference in conjunctival injection between the groups was nonsignificant (P=0.30). Dorzolamide γ-cyclodextrin nanoparticle eye drops are no more locally toxic or irritating to the eye than Trusopt. Icelandic research council Research to prevent blindness in Iceland Technology Development Fund Swedish Medical Society Kempe Fund Oculis ehf Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Kempe ENVELOPE(162.717,162.717,-78.317,-78.317) Journal of Ocular Pharmacology and Therapeutics 30 6 464 467
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic Augnsjúkdómar
Lyfjagjöf
Animals
Carbonic Anhydrase Inhibitors
Delayed-Action Preparations
Drug Delivery Systems
Harderian Gland
Inflammation
Nanoparticles
Ophthalmic Solutions
Rabbits
Sulfonamides
Thiophenes
gamma-Cyclodextrins
spellingShingle Augnsjúkdómar
Lyfjagjöf
Animals
Carbonic Anhydrase Inhibitors
Delayed-Action Preparations
Drug Delivery Systems
Harderian Gland
Inflammation
Nanoparticles
Ophthalmic Solutions
Rabbits
Sulfonamides
Thiophenes
gamma-Cyclodextrins
Jóhannesson, Gauti
Moya-Ortega, Maria D
Asgrímsdóttir, Gudrun Marta
Agnarsson, Bjarni A
Lund, Sigrún H
Loftsson, Thorsteinn
Stefánsson, Einar
Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
topic_facet Augnsjúkdómar
Lyfjagjöf
Animals
Carbonic Anhydrase Inhibitors
Delayed-Action Preparations
Drug Delivery Systems
Harderian Gland
Inflammation
Nanoparticles
Ophthalmic Solutions
Rabbits
Sulfonamides
Thiophenes
gamma-Cyclodextrins
description To access publisher's full text version of this article click on the hyperlink at the bottom of the page Dorzolamide nanoparticle γ-cyclodextrin eye drops may prolong the effect of dorzolamide on intraocular pressure. We test whether the nanoparticle drops have an irritating or toxic effect on the eye in an in vivo rabbit model. Eighteen pigmented rabbits were divided into 4 groups receiving dorzolamide nanoparticle γ-cyclodextrin eye drops×1/day or×2/day, Trusopt® (dorzolamide HCl)×3/day, and untreated controls that received no drops. The rabbits received treatment for 1 month. After sacrifice, 33 eyes and 25 Harderian glands were evaluated for histopathology in a masked way. Mild inflammation was seen in 19/31 eyes and 13/23 Harderian glands. The difference in inflammation (n=eyes/n=glands)between the γ-cyclodextrin nanoparticle eye drops×1/day (n=5/5),×2/day (n=5/3), Trusopt (n=7/4), or untreated control (n=2/0) groups was nonsignificant in both eyes and glands (P=0.87 and P=0.92) Acute inflammation was seen in 1 Harderian gland that received γ-cyclodextrin nanoparticle eye drops×2/day. The difference in conjunctival injection between the groups was nonsignificant (P=0.30). Dorzolamide γ-cyclodextrin nanoparticle eye drops are no more locally toxic or irritating to the eye than Trusopt. Icelandic research council Research to prevent blindness in Iceland Technology Development Fund Swedish Medical Society Kempe Fund Oculis ehf
author2 Univ Iceland, Natl Univ Hosp, Dept Ophthalmol, IS-101 Reykjavik, Iceland, Univ Iceland, Natl Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland, Umea Univ, Dept Clin Sci, Umea, Sweden, Univ Iceland, Fac Pharmaceut Sci, IS-101 Reykjavik, Iceland, Oculis Ehf, Reykjavik, Iceland, Univ Iceland, Fac Med, Dept Publ Hlth, IS-101 Reykjavik, Iceland
format Article in Journal/Newspaper
author Jóhannesson, Gauti
Moya-Ortega, Maria D
Asgrímsdóttir, Gudrun Marta
Agnarsson, Bjarni A
Lund, Sigrún H
Loftsson, Thorsteinn
Stefánsson, Einar
author_facet Jóhannesson, Gauti
Moya-Ortega, Maria D
Asgrímsdóttir, Gudrun Marta
Agnarsson, Bjarni A
Lund, Sigrún H
Loftsson, Thorsteinn
Stefánsson, Einar
author_sort Jóhannesson, Gauti
title Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
title_short Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
title_full Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
title_fullStr Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
title_full_unstemmed Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
title_sort dorzolamide cyclodextrin nanoparticle suspension eye drops and trusopt in rabbit.
publisher Mary Ann Liebert, Inc.
publishDate 2015
url http://hdl.handle.net/2336/552274
https://doi.org/10.1089/jop.2013.0164
long_lat ENVELOPE(162.717,162.717,-78.317,-78.317)
geographic Kempe
geographic_facet Kempe
genre Iceland
genre_facet Iceland
op_relation http://dx.doi.org/ 10.1089/jop.2013.0164
J Ocul Pharmacol Ther. 2014, 30 (6):464-7
1557-7732
24734973
doi:10.1089/jop.2013.0164
http://hdl.handle.net/2336/552274
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
op_rights Archived with thanks to Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Closed - Lokað
op_doi https://doi.org/10.1089/jop.2013.0164
container_title Journal of Ocular Pharmacology and Therapeutics
container_volume 30
container_issue 6
container_start_page 464
op_container_end_page 467
_version_ 1766041582826422272